Role of Dendritic Cells in Graft-Versus-Host Disease
- 1 August 2002
- journal article
- review article
- Published by SAGE Publications in Journal of Hematotherapy & Stem Cell Research
- Vol. 11 (4) , 601-616
Abstract
A major barrier to successful allogeneic hematopoietic stem cell transplantation is graft-versus-host disease (GVHD). Until recently, the role of antigen presentation in the development of this disorder was unknown. The experimental finding that recipient antigen-presenting cells (APCs) were required for the development of CD8+ T cell-dependent GVHD has led to a fundamental reappraisal of our ideas concerning the pathogenesis of this disease. Following transplantation, the origin (donor or recipient), number, lineage, and function of APCs within the recipient are altered significantly. Studies that test the influence of each of these factors upon graft-versus-host responses, including graft-versus-tumor responses, are beginning to emerge and suggest that APCs, such as dendritic cells, constitute a potential target for therapeutic manipulation.Keywords
This publication has 135 references indexed in Scilit:
- Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cellsEuropean Journal of Immunology, 2001
- Transport of Peptide-MHC Class II Complexes in Developing Dendritic CellsScience, 2000
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999
- CCR6, a CC Chemokine Receptor that Interacts with Macrophage Inflammatory Protein 3α and Is Highly Expressed in Human Dendritic CellsJournal of Experimental Medicine, 1997
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- SELECTIVE DEPLETION OF CD8+ CELLS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER BONE MARROW TRANSPLANTATION A RANDOMIZED CONTROLLED TRIALTransplantation, 1994
- Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease.Journal of Experimental Medicine, 1992
- T CELL SUBSETS AND GRAFT-VERSUS-HOST DISEASETransplantation, 1987
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979
- STUDIES ON THE REACTION OF INJECTED HOMOLOGOUS LYMPHOID TISSUE CELLS AGAINST THE HOSTAnnals of the New York Academy of Sciences, 1958